跳至主要内容
临床试验/NCT03919097
NCT03919097已完成不适用

Retrospective Study to Identify Risk Factors for Atrial Fibrillation After Ablation of Atrial Flutter by Radiofrequency of the Cavotricuspid Isthmus.

José Castro1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年1月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Cardiac surgery antecedents

研究概览

简要总结

Atrial flutter is a common condition that is effectively treated by ablation using radiofrequency. Due to its feasibility, effectiveness and low procedural risk, radiofrequency ablation is a first-line treatment of atrial flutter.

Several studies have been published concerning the factors associated with the occurrence of atrial fibrillation during or after flutter ablation, in patients with and without clinical history of atrial fibrillation. 26 to 46% of patients are likely to develop it, according to ECG or Holter diagnoses. The figure rises to more than 50% with a diagnosis with an implantable loop recorder.

In patients without a prior history of atrial fibrillation before ablation, anticoagulants are routinely administered 4-6 weeks after flutter removal by most cardiologists.

Although there are no specific guidelines for anticoagulation after flutter ablation, it is currently recommended to treat the patient as for atrial fibrillation. It is therefore crucial to identify in advance patients at high risk of atrial fibrillation after flutter ablation, in order to assess the appropriateness of maintaining oral anticoagulant therapy.

The objectives of this study are:

  • to evaluate the frequency and identify the factors predicting the occurrence of atrial fibrillation after flutter ablation
  • to determine the risk of a stroke occurring in patients with atrial fibrillation after flutter ablation.

The database consists in patients of the CHU Brugmann Hospital treated between 1996 and 2018.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients treated at the CHU Brugmann Hospital for flutter ablation by radiofrequency between 1996 and 2018.

排除标准

  • 未提供

结局指标

主要结局

Cardiac surgery antecedents

时间窗: One day

Presence of cardiac surgery antecedents at the date of flutter ablation

Age at ablation

时间窗: One day

Age of the patient at the date of the flutter ablation

Gender

时间窗: One day

Gender of the patient at the date of the flutter ablation

Antecedents of ischemic cardiomyopathy

时间窗: One day

Antecedents of ischemic cardiomyopathy (yes/no) at the date of flutter ablation

Antecedents of dilated cardiomyopathy

时间窗: One day

Antecedents of dilated cardiomyopathy (yes/no) at the date of flutter ablation

Chronic pulmonal disease

时间窗: One day

Chronic pulmonal disease diagnosed at the date of flutter ablation

Stroke after flutter ablation

时间窗: One year

Occurence of stroke after the flutter ablation

Diabetes

时间窗: One day

Diabetes diagnosis (yes/no) at the date of flutter ablation

Arterial hypertension

时间窗: One day

Presence of arterial hypertension on the day of flutter ablation

Antecedents of stroke

时间窗: One day

Antecedents of stroke

Antecedents of peripheric thromboembolic events

时间窗: One day

Antecedents of thromboembolic events on the day of flutter ablation

Antecedents of cardiomyopathy

时间窗: One day

Antecedents of cardiomyopathy (yes/no) at the date of flutter ablation

Atrial fibrillation antecedents

时间窗: One day

Antecedents of Atrial fibrillation at the date of flutter ablation

Peripheric thromboembolic events after flutter ablation

时间窗: One year

Thromboembolic events after flutter ablation

Left ventricular ejection fraction of the heart

时间窗: One day

Left ventricular ejection fraction of the heart at the day of flutter removal (echographic data)

Beta-blockers post-ablation

时间窗: One day

Prescription of Beta-Blockers after the flutter ablation (yes/no)

Amiodarone post-ablation

时间窗: One year

Prescription of amiodarone after the flutter ablation (yes/no)

Left atrium size of the heart

时间窗: One day

Left atrium size of the heart at the day of flutter removal (echographic data)

Class I antiarrhythmic drugs post-ablation

时间窗: One year

Prescription of Class I antiarrhythmic drugs post-ablation

Pulmonary arterial pressure

时间窗: One day

Pulmonary arterial pressure at the day of flutter removal (echographic data)

Atrial Fibrillation apparition delay

时间窗: Up to one year

Delay of apparition of atrial fibrillation after flutter removal

次要结局

未报告次要终点

研究者

发起方
José Castro
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

José Castro

Head of cardiology clinic

Brugmann University Hospital

研究点 (1)

Loading locations...

相似试验